Phosphatidylinositol 3-kinase (PI3K) is strongly activated in cancer cells by the activation of receptor tyrosine kinase, a gain-of-function hotspot mutation in the PIK3CA gene or the loss of phosphatase and tensin homolog (PTEN) expression, thus contributing to oncogenesis, proliferation and survival [11, 12]. This evidence concerns the gene PTEN and cancer.